{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-015404","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2024-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.538825+00:00","generated_at":"2026-06-03T13:34:07.147904+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Oragenics receives NYSE American noncompliance notice; equity $3.2M below $4M/$6M thresholds","bullets":["NYSE American notified Oragenics it fails continued listing standards due to stockholders' equity of $3.2M as of Dec 31, 2023.","Company must submit a compliance plan by May 18, 2024 to address Sections 1003(a)(ii) and 1003(a)(iii) deficiencies.","Company has until October 18, 2025 to regain compliance; stock trades as OGEN.BC during this period.","If plan is not accepted or compliance not achieved, Oragenics faces potential delisting from NYSE American."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-015404","json":"https://secwatch.observer/filing/0001493152-24-015404.json","markdown":"https://secwatch.observer/filing/0001493152-24-015404.md","text":"https://secwatch.observer/filing/0001493152-24-015404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/0001493152-24-015404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T13:34:07.147904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a0cd5a987e48b27f0798fd7ecf7df625e5819bec","claim":"ORAGENICS INC received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).","evidence_excerpt":"or more if the listed company has reported losses from continuing operations and/or net losses in its five most recent fiscal years. The Company reported stockholders equity of $3.2 million as of December 31, 2023, and losses from continuing operations and/or net losses in its five most recent fiscal years ended December 31, 2023. The Notice further provides that","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224015404/0001493152-24-015404-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse american"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"1003(a)(ii), 1003(a)(iii)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}